
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lymph node-targeting nanovaccines for cancer immunotherapy
Qiu Wang, Zhe Wang, Xinxin Sun, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 102-122
Closed Access | Times Cited: 44
Qiu Wang, Zhe Wang, Xinxin Sun, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 102-122
Closed Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 103
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 103
Lymph-targeted high-density lipoprotein-mimetic nanovaccine for multi-antigenic personalized cancer immunotherapy
Mingqi Liu, Yang Feng, Yougong Lu, et al.
Science Advances (2024) Vol. 10, Iss. 11
Open Access | Times Cited: 30
Mingqi Liu, Yang Feng, Yougong Lu, et al.
Science Advances (2024) Vol. 10, Iss. 11
Open Access | Times Cited: 30
The quest for nanoparticle-powered vaccines in cancer immunotherapy
Zhe Sun, Hui Zhao, Li Ma, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24
Zhe Sun, Hui Zhao, Li Ma, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24
Nanoparticles Targeting Lymph Nodes for Cancer Immunotherapy: Strategies and Influencing Factors
Zi‐Zhan Li, Nian‐Nian Zhong, Lei‐Ming Cao, et al.
Small (2024) Vol. 20, Iss. 19
Closed Access | Times Cited: 20
Zi‐Zhan Li, Nian‐Nian Zhong, Lei‐Ming Cao, et al.
Small (2024) Vol. 20, Iss. 19
Closed Access | Times Cited: 20
Black Phosphorus Quantum Dot Loaded Bioinspired Nanoplatform Synergized with aPD-L1 for Multimode Cancer Immunotherapy
Yuqi Cao, Lu Tang, Cong Fu, et al.
Nano Letters (2024) Vol. 24, Iss. 22, pp. 6767-6777
Closed Access | Times Cited: 15
Yuqi Cao, Lu Tang, Cong Fu, et al.
Nano Letters (2024) Vol. 24, Iss. 22, pp. 6767-6777
Closed Access | Times Cited: 15
Invasion and metastasis in cancer: molecular insights and therapeutic targets
Yongxing Li, Fengshuo Liu, Qingjin Cai, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Yongxing Li, Fengshuo Liu, Qingjin Cai, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
mRNA Cancer Vaccines: Construction and Boosting Strategies
Xiaoqing Liu, Pei Huang, Rusen Yang, et al.
ACS Nano (2023) Vol. 17, Iss. 20, pp. 19550-19580
Closed Access | Times Cited: 39
Xiaoqing Liu, Pei Huang, Rusen Yang, et al.
ACS Nano (2023) Vol. 17, Iss. 20, pp. 19550-19580
Closed Access | Times Cited: 39
Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy
Ao He, Xiaoye Li, Zhuo Dai, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 30
Ao He, Xiaoye Li, Zhuo Dai, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 30
Harnessing Engineered Immune Cells and Bacteria as Drug Carriers for Cancer Immunotherapy
Jingwen Jiang, Yanjuan Huang, Zishan Zeng, et al.
ACS Nano (2023) Vol. 17, Iss. 2, pp. 843-884
Closed Access | Times Cited: 28
Jingwen Jiang, Yanjuan Huang, Zishan Zeng, et al.
ACS Nano (2023) Vol. 17, Iss. 2, pp. 843-884
Closed Access | Times Cited: 28
Injectable Nano-in-Gel Vaccine for Spatial and Temporal Control of Vaccine Kinetics and Breast Cancer Postsurgical Therapy
Taiyuan Liu, Xinghui Si, Liping Liu, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 3087-3100
Closed Access | Times Cited: 13
Taiyuan Liu, Xinghui Si, Liping Liu, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 3087-3100
Closed Access | Times Cited: 13
Engineering customized nanovaccines for enhanced cancer immunotherapy
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 11
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 11
Seizing the fate of lymph nodes in immunotherapy: To preserve or not?
Zhenyu Xu, Zi‐Zhan Li, Lei‐Ming Cao, et al.
Cancer Letters (2024) Vol. 588, pp. 216740-216740
Closed Access | Times Cited: 9
Zhenyu Xu, Zi‐Zhan Li, Lei‐Ming Cao, et al.
Cancer Letters (2024) Vol. 588, pp. 216740-216740
Closed Access | Times Cited: 9
Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance
Zhijie Xu, Zhou Hai-yan, Tongfei Li, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101098-101098
Closed Access | Times Cited: 9
Zhijie Xu, Zhou Hai-yan, Tongfei Li, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101098-101098
Closed Access | Times Cited: 9
Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1
Programmed T cells infiltration into lung metastases with harnessing dendritic cells in cancer immunotherapies by catalytic antigen-capture sponges
Min‐Ren Chiang, Wei‐Ting Shen, Pin‐Xuan Huang, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 260-273
Closed Access | Times Cited: 16
Min‐Ren Chiang, Wei‐Ting Shen, Pin‐Xuan Huang, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 260-273
Closed Access | Times Cited: 16
Elaborately engineering of lipid nanoparticle for targeting delivery of siRNA and suppressing acute liver injury
Qiu Wang, Qikun Jiang, Dan Li, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 2, pp. 108683-108683
Closed Access | Times Cited: 15
Qiu Wang, Qikun Jiang, Dan Li, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 2, pp. 108683-108683
Closed Access | Times Cited: 15
Poria cocos polysaccharide—functionalized graphene oxide nanosheet induces efficient cancer immunotherapy in mice
Jinning Yang, Xiaoxiao Dong, Boye Li, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 10
Open Access | Times Cited: 14
Jinning Yang, Xiaoxiao Dong, Boye Li, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 10
Open Access | Times Cited: 14
Nanotheranostics in cancer lymph node metastasis: The long road ahead
Kan Zhou, Zi‐Zhan Li, Ze‐Min Cai, et al.
Pharmacological Research (2023) Vol. 198, pp. 106989-106989
Open Access | Times Cited: 13
Kan Zhou, Zi‐Zhan Li, Ze‐Min Cai, et al.
Pharmacological Research (2023) Vol. 198, pp. 106989-106989
Open Access | Times Cited: 13
Current Advances and Future Prospects of Advanced Nanotechnology in Cancer Immunotherapy
Nanasaheb D. Thorat
(2025), pp. 191-204
Closed Access
Nanasaheb D. Thorat
(2025), pp. 191-204
Closed Access
The future of cancer vaccines against colorectal cancer
Wenqing Jia, Xiaonan Shen, Zichao Guo, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 4, pp. 269-284
Closed Access | Times Cited: 4
Wenqing Jia, Xiaonan Shen, Zichao Guo, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 4, pp. 269-284
Closed Access | Times Cited: 4
Engineering dendritic cell biomimetic membrane as a delivery system for tumor targeted therapy
Huiyang Liu, Yiming Lu, Jinbao Zong, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Huiyang Liu, Yiming Lu, Jinbao Zong, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Soluble-microneedle enhance three T-cell activation signals as efficient tumor vaccines for melanoma prevention and treatment
Nancy Li, Weiwei Mu, Zhenxing Xia, et al.
Journal of Controlled Release (2025), pp. 113726-113726
Closed Access
Nancy Li, Weiwei Mu, Zhenxing Xia, et al.
Journal of Controlled Release (2025), pp. 113726-113726
Closed Access
Hybrid Nanogel Drug Delivery Systems: Transforming the Tumor Microenvironment through Tumor Tissue Editing
Theodora Katopodi, Savvas Petanidis, George Floros, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 908-908
Open Access | Times Cited: 3
Theodora Katopodi, Savvas Petanidis, George Floros, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 908-908
Open Access | Times Cited: 3
Metal‐Free Atom Transfer Radical Polymerization to Prepare Recylable Micro‐Adjuvants for Dendritic Cell Vaccine
Hengyuan Zhang, Xingyu Heng, Yang He, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 24
Closed Access | Times Cited: 2
Hengyuan Zhang, Xingyu Heng, Yang He, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 24
Closed Access | Times Cited: 2
Precision Nanovaccines for Potent Vaccination
Hong Liu, Haolin Chen, Zeyu Yang, et al.
JACS Au (2024) Vol. 4, Iss. 8, pp. 2792-2810
Open Access | Times Cited: 2
Hong Liu, Haolin Chen, Zeyu Yang, et al.
JACS Au (2024) Vol. 4, Iss. 8, pp. 2792-2810
Open Access | Times Cited: 2